Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 7, 2012 - Issue 1
Submit an article Journal homepage
36
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Fibrillin-3 in the fetal ovary: can it contribute to polycystic ovary syndrome?

David H Abbott Department of Obstetrics and Gynecology and Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA. [email protected]
Pages 31-34 | Published online: 10 Jan 2014

References

  • Hatzirodos N, Bayne RA, Irving-Rodgers HF et al. Linkage of regulators of TGF-β activity in the fetal ovary to polycystic ovary syndrome. FASEB J.25(7), 2256–2265 (2011).
  • Robertson I, Jensen S, Handford P. TB domain proteins: evolutionary insights into the multifaceted roles of fibrillins and LTBPs. Biochem J.433(2), 263–276 (2011).
  • Sabatier L, Miosge N, Hubmacher D, Lin G, Davis EC, Reinhardt DP. Fibrillin-3 expression in human development. Matrix Biol.30(1), 43–52 (2011).
  • Massam-Wu T, Chiu M, Choudhury R et al. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J. Cell Sci.123(Pt 17), 3006–3018 (2010).
  • Sengle G, Ono RN, Sasaki T, Sakai LY. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. J. Biol. Chem.286(7), 5087–5099 (2011).
  • Jordan CD, Bohling SD, Charbonneau NL, Sakai LY. Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS? J. Histochem. Cytochem.58(10), 903–915 (2010).
  • Urbanek M, Woodroffe A, Ewens KG et al. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J. Clin. Endocrinol. Metab.90(12), 6623–6629 (2005).
  • Stewart DR, Dombroski BA, Urbanek M et al. Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J. Clin. Endocrinol. Metab.91(10), 4112–4117 (2006).
  • Tucci S, Futterweit W, Concepcion ES et al. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J. Clin. Endocrinol. Metab.86(1), 446–449 (2001).
  • Ewens KG, Stewart DR, Ankener W et al.Family-based analysis of candidate genes for polycystic ovary syndrome. J. Clin. Endocrinol. Metab.95(5), 2306–2315 (2010).
  • Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod.19(1), 41–47 (2004).
  • Wild RA, Carmina E, Diamanti-Kandarakis E et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab.95(5), 2038–2049 (2010).
  • Prodoehl MJ, Hatzirodos N, Irving-Rodgers HF et al. Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol. Hum. Reprod.15(12), 829–841 (2009).
  • Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum. Reprod. Update11(4), 357–374 (2005).
  • Padmanabhan V, Veiga-Lopez A. Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming. Semin. Reprod. Med.29(3), 173–186 (2011).
  • Shikanov A, Smith RM, Xu M, Woodruff TK, Shea LD. Hydrogel network design using multifunctional macromers to coordinate tissue maturation in ovarian follicle culture. Biomaterials32, 2524–2531 (2011).
  • Xu N, Kwon S, Abbott DH et al. Epigenetic mechanism underlying the development of a polycystic ovary syndrome (PCOS)-like phenotype in prenatally androgenized rhesus monkeys. PLoS ONE6, e27286 (2011).
  • Abbott DH, Barnett DK, Levine JE et al. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol. Reprod.79(1), 154–163 (2008).
  • Abbott DH, Bruns CR, Barnett DK et al. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring. Am. J. Physiol. Endocrinol. Metab.299(5), E741–E751 (2010).
  • Gaikwad AB, Gupta J, Tikoo K. Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions. Biochem. J.432, 333–341 (2010).
  • Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ343, d6309 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.